tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

INVO Fertility’s Recent Unregistered Equity Sale

Story Highlights
INVO Fertility’s Recent Unregistered Equity Sale

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

INVO Fertility ( (IVF) ) has provided an update.

On July 28, 2025, an institutional investor of INVO Fertility exercised its right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000, adjusting the conversion price to $1.8909 per share. This transaction was conducted without public offering registration, potentially impacting the company’s financial structure and market positioning.

The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.

Spark’s Take on IVF Stock

According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.

INVO Fertility’s overall stock score is primarily driven by its poor financial performance and negative technical indicators. While recent corporate events suggest potential capital expansion, the company’s high leverage and lack of profitability are significant concerns.

To see Spark’s full report on IVF stock, click here.

More about INVO Fertility

INVO Fertility, Inc. operates in the fertility industry, focusing on innovative reproductive technologies and services.

Average Trading Volume: 1,489,664

Technical Sentiment Signal: Sell

Current Market Cap: $1.69M

Find detailed analytics on IVF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1